Dov Wexler

3.3k total citations · 2 hit papers
39 papers, 2.5k citations indexed

About

Dov Wexler is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Nephrology. According to data from OpenAlex, Dov Wexler has authored 39 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 16 papers in Cardiology and Cardiovascular Medicine and 13 papers in Nephrology. Recurrent topics in Dov Wexler's work include Erythropoietin and Anemia Treatment (28 papers), Iron Metabolism and Disorders (21 papers) and Dialysis and Renal Disease Management (13 papers). Dov Wexler is often cited by papers focused on Erythropoietin and Anemia Treatment (28 papers), Iron Metabolism and Disorders (21 papers) and Dialysis and Renal Disease Management (13 papers). Dov Wexler collaborates with scholars based in Israel, United States and Switzerland. Dov Wexler's co-authors include Donald S. Silverberg, Adrian Iaina, Doron Schwartz, Gad Keren, David S. Sheps, Miriam Blum, Shoshana Steinbruch, Itzhak Shapira, Shlomo Laniado and Jacob George and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Dov Wexler

39 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations

2000 563 citations Donald S. Silverberg, Dov Wexler et al. Journal of the American College of Cardiology profile →
The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study

2001 501 citations Donald S. Silverberg, Dov Wexler et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dov Wexler Israel	26	1.5k	1.2k	625	431	240	39	2.5k
Reshma Kewalramani United States	19	1.3k 0.8×	309 0.3×	1.4k 2.2×	482 1.1×	238 1.0×	29	2.6k
Alhakam Hudaihed United States	13	597 0.4×	931 0.8×	254 0.4×	173 0.4×	188 0.8×	16	1.6k
Piotr Rozentryt Poland	20	749 0.5×	1.3k 1.2×	146 0.2×	272 0.6×	256 1.1×	92	2.6k
David Brosh Israel	21	474 0.3×	1.2k 1.0×	432 0.7×	117 0.3×	198 0.8×	52	2.1k
Roberto Marchioli Italy	23	378 0.2×	699 0.6×	135 0.2×	636 1.5×	205 0.9×	40	2.1k
Mareev VIu Russia	17	622 0.4×	1.3k 1.1×	103 0.2×	203 0.5×	213 0.9×	111	2.0k
Donatella Colaizzo Italy	28	1.3k 0.8×	700 0.6×	57 0.1×	294 0.7×	154 0.6×	84	2.5k
Tom D.J. Smilde Netherlands	19	277 0.2×	1.6k 1.4×	855 1.4×	82 0.2×	640 2.7×	30	2.4k
Nena Aleksic United States	25	1.1k 0.7×	856 0.7×	56 0.1×	223 0.5×	408 1.7×	31	2.4k
Jolanta Nowak Poland	14	605 0.4×	684 0.6×	85 0.1×	218 0.5×	152 0.6×	47	1.3k

Countries citing papers authored by Dov Wexler

Since Specialization

Citations

This map shows the geographic impact of Dov Wexler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dov Wexler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dov Wexler more than expected).

Fields of papers citing papers by Dov Wexler

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dov Wexler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dov Wexler. The network helps show where Dov Wexler may publish in the future.

Co-authorship network of co-authors of Dov Wexler

This figure shows the co-authorship network connecting the top 25 collaborators of Dov Wexler. A scholar is included among the top collaborators of Dov Wexler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dov Wexler. Dov Wexler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silverberg, Donald S., Dov Wexler, Adrian Iaina, & Doron Schwartz. (2010). ANAEMIA MANAGEMENT IN CARDIO RENAL DISEASE. Journal of Renal Care. 36(s1). 86–96. 11 indexed citations

Silverberg, Donald S., Adrian Iaina, Doron Schwartz, & Dov Wexler. (2010). Intravenous Iron in Heart Failure: Beyond Targeting Anemia. Current Heart Failure Reports. 8(1). 14–21. 17 indexed citations

Silverberg, Donald S., Dov Wexler, Alberto Palazzuoli, Adrian Iaina, & Doron Schwartz. (2009). The Anemia of Heart Failure. Acta Haematologica. 122(2-3). 109–119. 21 indexed citations

Charach, Gideon, Jacob George, Arnon Afek, et al.. (2009). Antibodies to Oxidized LDL as Predictors of Morbidity and Mortality in Patients With Chronic Heart Failure. Journal of Cardiac Failure. 15(9). 770–774. 15 indexed citations

Charach, Gideon, Jacob George, Arie Roth, et al.. (2009). Baseline Low-Density Lipoprotein Cholesterol Levels and Outcome in Patients With Heart Failure. The American Journal of Cardiology. 105(1). 100–104. 25 indexed citations

Silverberg, Donald S., Dov Wexler, Adrian Iaina, & Doron Schwartz. (2008). The correction of anemia in patients with the combination of chronic kidney disease and congestive heart failure may prevent progression of both conditions. Clinical and Experimental Nephrology. 13(2). 101–106. 30 indexed citations

Michowitz, Yoav, Yaron Arbel, Dov Wexler, et al.. (2007). Predictive value of high sensitivity CRP in patients with diastolic heart failure. International Journal of Cardiology. 125(3). 347–351. 43 indexed citations

Silverberg, Donald S., Shoshana Steinbruch, Dov Wexler, et al.. (2007). Improvement of anemia with erythropoietin and intravenous iron reduces sleep-related breathing disorders and improves daytime sleepiness in anemic patients with congestive heart failure. American Heart Journal. 154(5). 870–876. 32 indexed citations

Silverberg, Donald S., Dov Wexler, Adrian Iaina, & Doron Schwartz. (2006). The Interaction Between Heart Failure and Other Heart Diseases, Renal Failure, and Anemia. Seminars in Nephrology. 26(4). 296–306. 97 indexed citations

10.

Silverberg, Donald S., Dov Wexler, Adrian Iaina, et al.. (2006). Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. International Urology and Nephrology. 38(2). 295–310. 96 indexed citations

11.

George, Jacob, et al.. (2005). Usefulness of Anti-Oxidized LDL Antibody Determination for Assessment of Clinical Control in Patients with Heart Failure. European Journal of Heart Failure. 8(1). 58–62. 27 indexed citations

12.

Iaina, Adrian, Donald S. Silverberg, & Dov Wexler. (2005). Therapy Insight: congestive heart failure, chronic kidney disease and anemia, the cardio–renal–anemia syndrome. Nature Clinical Practice Cardiovascular Medicine. 2(2). 95–100. 26 indexed citations

13.

Silverberg, Donald S., Dov Wexler, Miriam Blum, et al.. (2005). Erythropoietin in Heart Failure. Seminars in Nephrology. 25(6). 397–403. 23 indexed citations

14.

Silverberg, Donald S., Dov Wexler, & Adrian Iaina. (2004). The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?. Journal of Nephrology. 17(6). 749–761. 64 indexed citations

15.

Silverberg, Donald S., Dov Wexler, & Adrian Iaina. (2004). The Role of Anemia in Congestive Heart Failure and Chronic Kidney Insufficiency: the cardio renal anemia syndrome. Perspectives in biology and medicine. 47(4). 575–589. 16 indexed citations

16.

Silverberg, Donald S., Dov Wexler, Miriam Blum, et al.. (2004). Effects of Treatment with Epoetin Beta on Outcomes in Patients with Anaemia and Chronic Heart Failure. Kidney & Blood Pressure Research. 28(1). 41–47. 39 indexed citations

17.

Silverberg, Donald S., et al.. (2003). Erythropoietin should be part of congestive heart failure management. Kidney International. 64(87). S40–S47. 36 indexed citations

18.

Silverberg, Donald S., Dov Wexler, & Adrian Iaina. (2002). The Importance of Anemia and its Correction in the Management of Severe Congestive Heart Failures. European Journal of Heart Failure. 4(6). 681–686. 134 indexed citations

19.

Silverberg, Donald S., Dov Wexler, David S. Sheps, et al.. (2001). The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. Journal of the American College of Cardiology. 37(7). 1775–1780. 501 indexed citations breakdown →

20.

Rozenman, Yoseph, Dan Gilon, Sima Welber, et al.. (1994). Total Coronary Artery Occlusion Late after Successful Coronary Angioplasty of Moderately Severe Lesions: Incidence and Clinical Manifestations. Cardiology. 85(3-4). 222–228. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact